期刊文献+

1,25二羟维生素D_3对子宫内膜癌HEC-1-A细胞Skp2 mRNA的影响 被引量:1

The effect of 1,25(OH)_2D_3 on expression of Skp2 mRNA in endometrial carcinoma cell HEC-1-A
下载PDF
导出
摘要 目的检测1,25二羟维生素D3〔1,25(OH)2D3〕对人子宫内膜癌HEC-1-A细胞作用后S期激酶相关蛋白(Skp2)表达情况,以探讨其抗癌机制;方法选用人子宫内膜癌细胞株HEC-1-A进行体外培养,采用RT-PCR在mRNA水平检测Skp2基因表达的变化;结果 (10-8-10-6)mol.L-1浓度的1,25(OH)2D3作用于HEC-1-A细胞随着作用浓度增加、作用时间延长,细胞增殖能力逐渐下降,Skp2mRNA逐渐减少;结论 1,25(OH)2D3对人子宫内膜癌细胞株HEC-1-A有抑制作用,可能通过转录水平下调Skp2基因表达,从而产生抑癌作用。 OBJECTIVE To study the mechanism of 1, 25 (OH)2D3 on human endometrial carcinoma cell HEC-1-A by detecting the expression of S-phase kinase associated protein 2 (Skp2) gene. METHODS Human endometrial carcinoma cells HEC-1-A were cultured in vitro and the expression level of Skp2 mRNA was examined by reversed transcript polymerase chain reaction (RT-PCR). RESULTS The results showed that (10^-8-10^-6)mol·L^-1 1,25(OH)2D3 inhibited the proliferation of HEC-1-A cell line, and the mRNA expression of Skp2 in HEC-1-A cell lines after 1,25 (OH)2D3 treatment decreased with concentration of 1,25(OH)2D3 and treatment time. CONCLUSION 1,25(OH)2D3 can inhibit the growth of HEC-1-A cell line. It may inhibit cancer cell proliferation through down-regulation of Skp2 gene.
作者 林兰 郑秀
出处 《海峡药学》 2010年第4期161-164,共4页 Strait Pharmaceutical Journal
基金 福建医科大学教授学术发展基金(编号:JS06042)资助
关键词 1 25二羟维生素D3 子宫内膜癌 SKP2 1,25 (OH) 2D3 endometrial carcinoma cell Skp2
  • 相关文献

参考文献10

  • 1Nagpal S,Na S,Rathnaehalam R,Noncalcemic,actiohs of Vitamin D receptorligands[J].Endocr Rev,2005,26 (5):662 -687.
  • 2Zhang H,Kobayashi R,Galaktionov K,et al.pl9Skpl and p45 Skp2 areessential elements of the cyclin A-CDK2 Shase kinase[J].Cell,1995,82(6):915 -925.
  • 3Ezve S.Matsumura I,Nakata S,et al.GA TA22Pestrogen receptor chimeraregulates cytokine2 dependent growth of hematopoietic cells throughaccumulation of p21(WAFl) and p27(Kipl) proteins[J].Blood,2002,100(10):3512-3520.
  • 4Liang M,Liang YY,Wrighton K,et al.Ubiquitination and proteolysls ofcancer derived Smad4 mutants by SCF Skp2[J].Mol Cell Biol,2004,24(1):157-168.
  • 5Farhana L,Dswson M,Rishi AK,et al.CyclinB and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 areregulated by the ubiquitirr mediated path-way[J].Cancer Res,2002,62(13):3842-3849.
  • 6Yang G,Ayala G,Marzo AD,et al.Elevated Skp2 protein expression in human prostate cancer:Association With IOSS of the cyclin-dependent kinaseinhibitor p27 and PTEN and with reduced recurrence-free survival[J].Clin Cancer Res,2002,8 (11):3419-3426.
  • 7Vonderlehr N,Johansson S,Wu S,et al.The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor tor c-Myc-regulated transcription[J].Mol Cell,2003,11(5):1189-1200.
  • 8Kamata Y,Watanabe J,Nishimura Y,et al.High expression of Skp2 correlates With poor prognosis in endometrial en-dometrioid adenocarcinoma[J].Cancer Res Clin Oncol,2005,131(9):591-596.
  • 9王金华 郑秀 江忠清等.Skp2和p27在子宫内膜癌中的表达及与临床病理特征关系的研究.中华肿瘤防治杂志,2006,13(20):32-37.
  • 10Yabushita H,Hitata M,Noguch M,et al.Vitamin D receptor in endometrial carcinoma and the difierentiation inducing effect of 1,25-dihydroxyvitamin D3 on endometrial carcinoma cell lines[J]J Obstet Gynaecol Res.1996;22 (6):529 -539.

同被引文献7

  • 1Napolitamo U,Imperato F,Mossa B. The role of neoadjuvant chemotherapy for squamouscell cervical (Ⅰb-Ⅲb):A long term randomized trial[J].European Journal of Gynaecological Oncology,2003,(01):51-59.
  • 2Park DC,Kim JH,Lew YO. Phase Ⅱ trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer[J].Gynecologic Oncology,2004,(01):59-63.doi:10.1016/j.ygyno.2003.09.015.
  • 3Nagpal S,Na S,Rathnachalam R. Noncalcemic actions of Vitamin D receptor ligands[J].Endocrine Reviews,2005,(05):662-687.
  • 4Prosser DE,Kaufmann M,Oleary B. Single A326G mutation converis human CYP24A1 from 25-OH-D3-24-hydroxylaseinto-23-hydroxylase,generatinglalpha,25-(OH)2D3-26,23-lactone[J].Proceedings of the National Academy of Sciences(USA),2007,(31):12673-13678.doi:10.1073/pnas.0702093104.
  • 5Peterlik M,Grant WB,Cross HS. Calcium,vitamin D and cancer[J].Anticancer Research,2009,(09):3687-3698.
  • 6Vigan P,Lattuada D,Mangioni S. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system[J].Journal of Molecular Endocrinology,2006,(03):415-424.
  • 7Reichrath J,Rafi L,Muller SM. Immunohistochernical analysis of 1,25-dihydroxyvitaminD3 receptorin cervical carcinoma[J].Histochern,1998,(08):561-567.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部